Orpha Biotech Logo

About

Orpha Biotech is dedicated to developing innovative solutions for the treatment of rare ‘orphan’ diseases. Its initial targets are a group of orphan autoimmune diseases that may have common pathogenic pathways, namely systemic sclerosis and juvenile rheumatoid arthritis. Its discovery approach is to use structure-based computational ‘virtual screening’ and allied docking simulations to discover potential agonist or antagonist NCEs.  

Orpha Biotech

Founded

2018